#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cholangitis sclerosing Breast angiosarcoma Ichthyosis Biotinidase deficiency Paroxysmal nocturnal haemoglobinuria Infertility female Fibrodysplasia ossificans progressiva Ocular lymphoma Thrombotic thrombocytopenic purpura Philadelphia positive acute lymphocytic leukaemia Colorectal cancer metastatic Fragile X syndrome Neuropathic arthropathy Hidradenitis Congenital hypotransferrinaemia More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy – Basic Information Glycogen storage disease type V – Life with Disease Propionic acidaemia – Diagnostics Combined immunodeficiency – Basic Information Sjogren’s syndrome – Life with Disease Idiopathic pulmonary fibrosis Hereditary neuropathic amyloidosis – Diagnostics Systemic sclerosis pulmonary – Life with Disease Optic glioma – Life with Disease Haemophilia A without inhibitors – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dobutamine Hydrochloride Gandotinib Dextran 70 Dotatate Choriogonadotropin Alfa Letermovir Mva-209-Fsp-B4 Fludrocortisone Catequentinib Dihydrochloride Dordaviprone Brepocitinib Tosilate Gemcitabine Hydrochloride Sodium Nitrite Bromocriptine Eliglustat Tartrate Nirmatrelvir Bgb-A445 Ict01 Interleukin-1 Magnesium Chloride Hexahydrate More therapies…

    Learn about Your Condition

    Status epilepticus Cirrhosis alcoholic Thrombolysis Cachexia Rectal neoplasm Cholangitis sclerosing Pleural mesothelioma Thyroid cancer metastatic Femoral hernia Knee arthroplasty Diabetic neuropathy Lichen sclerosus Asymptomatic HIV infection Hypochromic anaemia Langerhans cell sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Ziekenhuis Gelderse Vallei Stichting

Ziekenhuis Gelderse Vallei Stichting

Willy Brandtlaan 10, Ede, 6716 RP, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Venetoclax and Epcoritamab for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Epcoritamab
    • Venetoclax
    Belgium Denmark Germany The Netherlands

  • Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

    Recruiting

    3 1
    Investigated Diseases:
    • Cardiac failure
    • Obesity
    Bulgaria Czechia Denmark France Germany Greece +4

  • Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Selatogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Austria Belgium Czechia Denmark France Germany +8

  • Rituximab and venetoclax treatment for 6 vs 26 cycles in patients with relapsed or refractory chronic lymphocytic leukemia

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Venetoclax
    The Netherlands

  • Study on Stopping Atorvastatin in Frail Patients Aged 70+ with Recent Ischemic Stroke or Transient Ischemic Attack

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Ischaemic stroke
    Investigated Drugs:
    • Atorvastatin
    The Netherlands

  • Study of inhaled interferon beta-1a (SNG001) for treatment of patients with viral lower respiratory tract infections who require mechanical ventilation

    Not recruiting

    2 1
    Investigated Drugs:
    • Interferon Beta-1A
    Belgium France The Netherlands Spain

  • Study of ifinatamab deruxtecan alone or in combination with other treatments for patients with metastatic castration-resistant prostate cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    • Abiraterone
    • Buclizine Hydrochloride
    France Germany Ireland Italy The Netherlands Poland +1

  • Study comparing carboplatin-cyclophosphamide versus paclitaxel with atezolizumab as first treatment for advanced triple negative breast cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Carboplatin
    The Netherlands

  • Study Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Domvanalimab
    • Zimberelimab
    • Carboplatin
    Austria Belgium France Germany Italy The Netherlands +2
Previous Page
1 2 3 4 5 6
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!